{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T16:41:03Z","timestamp":1721925663823},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,2,15]],"date-time":"2005-02-15T00:00:00Z","timestamp":1108425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,2,15]],"date-time":"2005-02-15T00:00:00Z","timestamp":1108425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hered Cancer Clin Pract"],"DOI":"10.1186\/1897-4287-3-1-19","type":"journal-article","created":{"date-parts":[[2010,3,11]],"date-time":"2010-03-11T19:14:40Z","timestamp":1268334880000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Withdrawal from Genetic Counselling for Cancer"],"prefix":"10.1186","volume":"3","author":[{"given":"Eveline","family":"Bleiker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gea","family":"Wigbout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"van Rens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senno","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"van't Veer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,2,15]]},"reference":[{"issue":"5182","key":"38_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Thanh T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Waray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow P, Norris F, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick M: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994,266(5182):66\u201371. 10.1126\/science.7545954","journal-title":"Science"},{"issue":"6559","key":"38_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G: Identification of the breast cancer susceptibility gene BRCA2. Nature 1995,378(6559):789\u2013792. 10.1038\/378789a0","journal-title":"Nature"},{"issue":"2","key":"38_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0165-4608(98)00165-4","volume":"109","author":"HT Lynch","year":"1999","unstructured":"Lynch HT, Watson P, Tinley S, Snyder C, Durham C, Lynch J, Kirnarsky Y, Serova O, Lenoir G, Lerman C, Narod SA: An update on DNA-based BRCA1\/BRCA2 genetic counseling in hereditary breast cancer. Cancer Genet Cytogenet 1999,109(2):91\u201398. 10.1016\/S0165-4608(98)00165-4","journal-title":"Cancer Genet Cytogenet"},{"issue":"1-2","key":"38_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0738-3991(97)00067-0","volume":"32","author":"EM Bleiker","year":"1997","unstructured":"Bleiker EM, Aaronson NK, Menko FH, Hahn DE, van Asperen CJ, Rutgers EJ, ten Kate LP, Leschot NJ: Genetic counseling for hereditary cancer: a pilot study on experiences of patients and family members. Patient Educ Couns 1997,32(1\u20132):107\u2013116. 10.1016\/S0738-3991(97)00067-0","journal-title":"Patient Educ Couns"},{"issue":"3","key":"38_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/jmg.37.3.197","volume":"37","author":"K Brain","year":"2000","unstructured":"Brain K, Gray J, Norman P, Parsons E, Clarke A, Rogers C, Mansel R, Harper P: Why do women attend familial breast cancer clinics? J Med Genet 2000,37(3):197\u2013202. 10.1136\/jmg.37.3.197","journal-title":"J Med Genet"},{"issue":"3","key":"38_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1089\/109065702761403360","volume":"6","author":"R Brandt","year":"2002","unstructured":"Brandt R, Hartmann E, Ali Z, Tucci R, Gilman P: Motivations and concerns of women considering genetic testing for breast cancer: a comparison between affected and at-risk probands. Genet Test 2002,6(3):203\u2013205. 10.1089\/109065702761403360","journal-title":"Genet Test"},{"issue":"3","key":"38_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ajmg.1320570304","volume":"57","author":"C Lerman","year":"1995","unstructured":"Lerman C, Seay J, Balshem A, Audrain J: Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995,57(3):385\u2013392. 10.1002\/ajmg.1320570304","journal-title":"Am J Med Genet"},{"issue":"24","key":"38_CR8","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1001\/jama.1996.03530480027036","volume":"275","author":"C Lerman","year":"1996","unstructured":"Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H: BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 1996,275(24):1885\u20131892. 10.1001\/jama.275.24.1885","journal-title":"JAMA"},{"issue":"1","key":"38_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1023\/A:1009451213035","volume":"10","author":"KP Geer","year":"2001","unstructured":"Geer KP, Ropka ME, Cohn WF, Jones SM, Miesfeldt S: Factors influencing patients' decisions to decline cancer genetic counseling services. J Genet Couns 2001,10(1):25\u201340. 10.1023\/A:1009451213035","journal-title":"J Genet Couns"},{"issue":"1","key":"38_CR10","first-page":"79","volume":"11","author":"EA Peterson","year":"2002","unstructured":"Peterson EA, Milliron KJ, Lewis KE, Goold SD, Merajver SD: Health insurance and discrimination concerns and BRCA1\/2 testing in a clinic population. Cancer Epidemiol Biomarkers Prev 2002,11(1):79\u201387.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"38_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/00125817-200007000-00003","volume":"2","author":"MA Hall","year":"2000","unstructured":"Hall MA, Rich SS: Patients' fear of genetic discrimination by health insurers: the impact of legal protections. Genet Med 2000,2(4):214\u2013221. 10.1097\/00125817-200007000-00003","journal-title":"Genet Med"},{"issue":"11","key":"38_CR12","first-page":"1251","volume":"9","author":"K Armstrong","year":"2000","unstructured":"Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B: Factors associated with decisions about clinical BRCA1\/2 testing. Cancer Epidemiol Biomarkers Prev 2000,9(11):1251\u20131254.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"38_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/109065704323016003","volume":"8","author":"C Foster","year":"2004","unstructured":"Foster C, Evans DGR, Eeles R, Eccles D, Ashley S, Brooks L, Cole T, Cook J, Davidson R, Gregory H, Mackay J, Morrison PJ, Watson M: Non-uptake of predictive genetic testing for BRCA1\/2: attributes, cancer worry, and barriers to testing in a multi-centre clinical cohort. Genet Test 2004,8(1):23\u201329. 10.1089\/109065704323016003","journal-title":"Genet Test"},{"issue":"5","key":"38_CR14","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1200\/JCO.1998.16.5.1650","volume":"16","author":"C Lerman","year":"1998","unstructured":"Lerman C, Hughes C, Lemon SJ, Main D, Snyder C, Durham C, Narod S, Lynch HT: What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol 1998,16(5):1650\u20131654.","journal-title":"J Clin Oncol"},{"issue":"3","key":"38_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ajmg.a.10168","volume":"119A","author":"L Lodder","year":"2003","unstructured":"Lodder L, Frets PG, Trijsburg RW, Klijn JG, Seynaeve C, Tilanus MM, Bartels CC, Meijers-Heijboer EJ, Verhoog LC, Niermeijer MF: Attitudes and distress levels in women at risk to carry a BRCA1\/BRCA2 gene mutation who decline genetic testing. Am J Med Genet 2003,119A(3):266\u2013272. 10.1002\/ajmg.a.10168","journal-title":"Am J Med Genet"},{"key":"38_CR16","first-page":"61","volume":"8","author":"HB Valdimarsdottir","year":"1999","unstructured":"Valdimarsdottir HB, Bovbjerg DH, Brown K, Jacobsen P, Schwartz MD, Bleiker E, Offit K, Borgen P, Heerdt A, van Zee K: Cancer-specific distress is related to women's decisions to undergo BCRA1-testing. Cancer Res Ther Control 1999, 8: 61\u201368.","journal-title":"Cancer Res Ther Control"},{"issue":"3","key":"38_CR17","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1037\/0022-006X.65.3.414","volume":"65","author":"C Lerman","year":"1997","unstructured":"Lerman C, Schwartz MD, Lin TH, Hughes C, Narod S, Lynch HT: The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 1997,65(3):414\u2013420. 10.1037\/0022-006X.65.3.414","journal-title":"J Consult Clin Psychol"},{"issue":"12","key":"38_CR18","first-page":"1579","volume":"11","author":"HS Thompson","year":"2002","unstructured":"Thompson HS, Valdimarsdottir HB, Duteau-Buck C, Guevarra J, Bovbjerg DH, Richmond-Avellaneda C, Amarel D, Godfrey D, Brown K, Offit K: Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol Biomarkers Prev 2002,11(12):1579\u20131585.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"38_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/(SICI)1096-8628(19970711)71:1<63::AID-AJMG12>3.0.CO;2-T","volume":"71","author":"AC DudokdeWit","year":"1997","unstructured":"DudokdeWit AC, Tibben A, Frets PG, Meijers-Heijboer EJ, Devilee P, Klijn JG, Oosterwijk JC, Niermeijer MF: BRCA1 in the family: a case description of the psychological implications. Am J Med Genet 1997,71(1):63\u201371. 10.1002\/(SICI)1096-8628(19970711)71:1<63::AID-AJMG12>3.0.CO;2-T","journal-title":"Am J Med Genet"},{"issue":"1","key":"38_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ajmg.1320480105","volume":"48","author":"A Tibben","year":"1993","unstructured":"Tibben A, Frets PG, Kamp JJ, Niermeijer MF, Vlis M, Roos RA, van Ommen GJ, Duivenvoorden HJ, Verhage F: Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program. Am J Med Genet 1993,48(1):10\u201316. 10.1002\/ajmg.1320480105","journal-title":"Am J Med Genet"},{"key":"38_CR21","volume-title":"SF-36 Health Survey: Manual and Interpretation Guide","author":"JE Ware","year":"1993","unstructured":"Ware JE, Snow KK, Kosinski M, Gandek B: SF-36 Health Survey: Manual and Interpretation Guide. Boston, M. A. New England Medical Center, The Health Institute; 1993."},{"issue":"11","key":"38_CR22","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0895-4356(98)00097-3","volume":"51","author":"NK Aaronson","year":"1998","unstructured":"Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E: Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998,51(11):1055\u20131068. 10.1016\/S0895-4356(98)00097-3","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"38_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00006842-197905000-00004","volume":"41","author":"M Horowitz","year":"1979","unstructured":"Horowitz M, Wilner N, Alvarez W: Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979,41(3):209\u2013218.","journal-title":"Psychosom Med"},{"key":"38_CR24","first-page":"164","volume":"40","author":"D Brom","year":"1985","unstructured":"Brom D, Kleber RJ: De schok verwerkingslijst [Impact of Event Scale]. Ned Tijdschr Psychol 1985, 40: 164\u2013168.","journal-title":"Ned Tijdschr Psychol"},{"key":"38_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/pon.2960040207","volume":"4","author":"HB Valdimarsdottir","year":"1995","unstructured":"Valdimarsdottir HB, Bovbjerg DH, Kash KM, Holland JC, Osborne MP, Miller DG: Psychological distress in women with a familial risk of breast cancer. Psycho-oncology 1995, 4: 133\u2013141. 10.1002\/pon.2960040207","journal-title":"Psycho-oncology"},{"issue":"4","key":"38_CR26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1200\/JCO.1994.12.4.843","volume":"12","author":"C Lerman","year":"1994","unstructured":"Lerman C, Daly M, Masny A, Balshem A: Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994,12(4):843\u2013850.","journal-title":"J Clin Oncol"},{"issue":"5","key":"38_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/00006842-199709000-00001","volume":"59","author":"PB Jacobsen","year":"1997","unstructured":"Jacobsen PB, Valdimarsdottir HB, Brown KL, Offit K: Decision-making about genetic testing among women at familial risk for breast cancer. Psychosom Med 1997,59(5):459\u2013466.","journal-title":"Psychosom Med"}],"container-title":["Hereditary Cancer in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1897-4287-3-1-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1897-4287-3-1-19\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1897-4287-3-1-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T16:01:01Z","timestamp":1721923261000},"score":1,"resource":{"primary":{"URL":"https:\/\/hccpjournal.biomedcentral.com\/articles\/10.1186\/1897-4287-3-1-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,15]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1186\/1897-4287-3-1-19","relation":{},"ISSN":["1897-4287"],"issn-type":[{"value":"1897-4287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,15]]},"assertion":[{"value":"31 January 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"19"}}